Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TUNE DYREKLINIK ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.4% 3.4% 2.0% 1.6% 1.1% 3.8% 11.0% 10.9%   Credit score (0-100)   43 55 68 72 84 45 5 5   Credit rating   BB BB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.3 4.1 113.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,006 3,621 4,666 4,466 4,989 4,508 0.0 0.0   EBITDA   104 346 861 812 1,147 227 0.0 0.0   EBIT   27.2 194 643 513 844 -68.2 0.0 0.0   Pre-tax profit (PTP)   12.9 174.8 612.8 530.5 878.7 -92.7 0.0 0.0   Net earnings   3.3 137.5 474.4 410.0 686.6 -82.9 0.0 0.0   Pre-tax profit without non-rec. items   12.9 175 613 531 879 -92.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   419 831 1,104 1,460 1,200 1,338 0.0 0.0   Shareholders equity total   247 385 859 1,119 1,656 1,373 1,143 1,143   Interest-bearing liabilities   630 586 433 519 553 674 0.0 0.0   Balance sheet total (assets)   1,809 2,214 2,932 3,279 3,271 3,137 1,143 1,143   Net Debt   562 578 220 509 546 649 -1,143 -1,143     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,006 3,621 4,666 4,466 4,989 4,508 0.0 0.0   Gross profit growth   -6.7% 20.5% 28.9% -4.3% 11.7% -9.6% -100.0% 0.0%   Employees   6 8 8 8 7 8 0 0   Employee growth %   0.0% 33.3% 0.0% 0.0% -12.5% 14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,809 2,214 2,932 3,279 3,271 3,137 1,143 1,143   Balance sheet change%   10.7% 22.4% 32.5% 11.8% -0.2% -4.1% -63.6% 0.0%   Added value   103.6 345.9 861.2 811.7 1,143.2 227.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   33 260 54 57 -563 -158 -1,338 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.9% 5.4% 13.8% 11.5% 16.9% -1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.8% 11.0% 25.0% 17.9% 27.5% -0.7% 0.0% 0.0%   ROI %   5.5% 20.8% 50.7% 35.3% 44.8% -1.0% 0.0% 0.0%   ROE %   1.3% 43.5% 76.3% 41.4% 49.5% -5.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   13.7% 17.4% 29.3% 34.1% 50.6% 43.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   542.9% 167.0% 25.6% 62.8% 47.6% 285.9% 0.0% 0.0%   Gearing %   254.6% 152.2% 50.3% 46.4% 33.4% 49.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.3% 7.8% 5.9% 5.2% 4.0% 11.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.6 0.6 0.6 0.9 0.7 0.0 0.0   Current Ratio   0.8 0.7 0.8 0.7 1.2 0.9 0.0 0.0   Cash and cash equivalent   67.3 7.8 212.4 9.8 7.2 24.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -308.8 -582.8 -390.7 -535.1 269.5 -163.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   17 43 108 101 163 28 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   17 43 108 101 164 28 0 0   EBIT / employee   5 24 80 64 121 -9 0 0   Net earnings / employee   1 17 59 51 98 -10 0 0